Results 211 to 220 of about 16,449,484 (363)
TEAD-independent mechanisms of YAP function in cardiomyocyte cell cycle reentry. [PDF]
Xie B +10 more
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
A vertically integrated system for tracking and assessing cell-cycle-aware phenotypes under confinement. [PDF]
Pezzotti M +7 more
europepmc +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
Esomeprazole inhibits proliferation of scleroderma fibroblasts via cell cycle regulation. [PDF]
Khan MA +9 more
europepmc +1 more source
Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.
A. Sakaue-Sawano +13 more
semanticscholar +1 more source
Correlation of the differential expression of PIK3R1 and its spliced variant, p55α, in pan‐cancer
PIK3R1 undergoes alternative splicing to generate the isoforms, p85α and p55α. By combining large patient datasets with laboratory experiments, we show that PIK3R1 spliced variants shape cancer behavior. While tumors lose the protective p85α isoform, p55α is overexpressed, changes linked to poorer survival and more pronounced in African American ...
Ishita Gupta +10 more
wiley +1 more source
Cell cycle, cell division, cell death
Maddox, Amy Shaub, Skotheim, Jan M.
openaire +2 more sources

